{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T05:54:57Z","timestamp":1768542897012,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2000,8,1]],"date-time":"2000-08-01T00:00:00Z","timestamp":965088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2000,8,1]],"date-time":"2000-08-01T00:00:00Z","timestamp":965088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2000,8]]},"DOI":"10.1053\/ajkd.2000.8970","type":"journal-article","created":{"date-parts":[[2008,3,20]],"date-time":"2008-03-20T21:11:45Z","timestamp":1206047505000},"page":"266-271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Progress in blood pressure control in autosomal dominant polycystic kidney disease"],"prefix":"10.1053","volume":"36","author":[{"given":"Tevfik","family":"Ecder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles L.","family":"Edelstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Godela M.","family":"Fick-Brosnahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann M.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene T.","family":"Duley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia A.","family":"Gabow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert W.","family":"Schrier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/ajkd.2000.8970_bib1","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/ki.1990.330","article-title":"Renal structure and hypertension in autosomal dominant polycystic kidney disease","volume":"38","author":"Gabow","year":"1990","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2000.8970_bib2","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/ki.1992.195","article-title":"Factors affecting the progression of renal disease in autosomal dominant polycystic kidney disease","volume":"41","author":"Gabow","year":"1992","journal-title":"Kidney Int"},{"issue":"suppl 6","key":"10.1053\/ajkd.2000.8970_bib3","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1093\/ndt\/10.supp6.15","article-title":"Hypertension as a factor in chronic renal insufficiency progression in polycystic kidney disease","volume":"10","author":"Marcelli","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2000.8970_bib4","first-page":"653","article-title":"Pathogenesis of hypertension in autosomal dominant polycystic kidney disease","volume":"11","author":"Chapman","year":"1991","journal-title":"Semin Nephrol"},{"key":"10.1053\/ajkd.2000.8970_bib5","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1681\/ASN.V881292","article-title":"Left ventricular hypertrophy in autosomal dominant polycystic kidney disease","volume":"8","author":"Chapman","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/ajkd.2000.8970_bib6","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1681\/ASN.V5122048","article-title":"Causes of death in autosomal dominant polycystic kidney disease","volume":"5","author":"Fick","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/ajkd.2000.8970_bib7","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1001\/archinte.1997.00440420033005","article-title":"The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","volume":"157","author":"The Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure and the National High Blood Pressure Education Program Coordinating Committee","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1053\/ajkd.2000.8970_bib8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearances from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.1053\/ajkd.2000.8970_bib9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1161\/01.HYP.26.1.60","article-title":"Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the Health Examination Surveys, 1960 to 1991","volume":"26","author":"Burt","year":"1995","journal-title":"Hypertension"},{"key":"10.1053\/ajkd.2000.8970_bib10","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1161\/01.HYP.25.3.305","article-title":"Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991","volume":"25","author":"Burt","year":"1995","journal-title":"Hypertension"},{"key":"10.1053\/ajkd.2000.8970_bib11","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0895-7061(97)00224-0","article-title":"Awareness, treatment, and control of hypertension in Canada","volume":"10","author":"Joffres","year":"1997","journal-title":"Am J Hypertens"},{"key":"10.1053\/ajkd.2000.8970_bib12","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/00004872-199816060-00005","article-title":"Blood pressure screening, management and control in England: Results from the health survey for England, 1994","volume":"16","author":"Colhoun","year":"1998","journal-title":"J Hypertens"},{"issue":"suppl 1","key":"10.1053\/ajkd.2000.8970_bib13","first-page":"S45","article-title":"Actual blood pressure control: Are we doing things right?","volume":"16","author":"Coca","year":"1998","journal-title":"J Hypertens"},{"key":"10.1053\/ajkd.2000.8970_bib14","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0895-7061(98)00071-5","article-title":"Prevalence, treatment, and control of hypertension in the French population. Data from a survey on high blood pressure in general practice, 1994","volume":"11","author":"Chamontin","year":"1998","journal-title":"Am J Hypertens"},{"key":"10.1053\/ajkd.2000.8970_bib15","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0895-7061(98)00068-5","article-title":"Treatment of high blood pressure in Germany","volume":"11","author":"Faulhaber","year":"1998","journal-title":"Am J Hypertens"},{"key":"10.1053\/ajkd.2000.8970_bib16","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomized trial","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/ajkd.2000.8970_bib17","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/geronj\/42.5.552","article-title":"Compliance to treatment for hypertension in elderly patients: The SHEP Pilot Study","volume":"42","author":"Black","year":"1987","journal-title":"J Gerontol"},{"key":"10.1053\/ajkd.2000.8970_bib18","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1001\/jama.1997.03550210043036","article-title":"Trends in antihypertensive drug use in the United States","volume":"278","author":"Siegel","year":"1997","journal-title":"JAMA"},{"key":"10.1053\/ajkd.2000.8970_bib19","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJM199010183231602","article-title":"The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease","volume":"323","author":"Chapman","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1053\/ajkd.2000.8970_bib20","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1053\/ajkd.2000.8970_bib21","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1056\/NEJM199604113341502","article-title":"Effect of the angiotensin-converting enzyme inhibitors on the progression of chronic renal insufficiency","volume":"334","author":"Maschio","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1053\/ajkd.2000.8970_bib22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.7326\/0003-4819-127-5-199709010-00001","article-title":"Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: A meta-analysis of randomized trials","volume":"127","author":"Giatras","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1053\/ajkd.2000.8970_bib23","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0140-6736(96)11445-8","article-title":"Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy","volume":"349","author":"The GISEN Group","year":"1997","journal-title":"Lancet"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638600720683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638600720683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:18:57Z","timestamp":1759454337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638600720683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,8]]}},"alternative-id":["S0272638600720683"],"URL":"https:\/\/doi.org\/10.1053\/ajkd.2000.8970","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2000,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progress in blood pressure control in autosomal dominant polycystic kidney disease","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/ajkd.2000.8970","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2000 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}